SG Americas Securities LLC significantly reduced its investment in Teleflex Incorporated (NYSE: TFX) by 50.6% during the third quarter of 2024. According to the latest 13F filing with the U.S. Securities and Exchange Commission, the institutional investor now holds 4,867 shares of the medical technology company after selling 4,994 shares during the quarter, with a value of approximately $596,000.
The shift in SG Americas’ holdings coincides with activity from other institutional investors. For instance, Russell Investments Group Ltd. increased its stake in Teleflex by 23.6% in the second quarter, acquiring 15,935 shares to reach a total of 83,388 shares, valued at around $9,870,000. Similarly, Speece Thorson Capital Group Inc. raised its holdings by 2.4%, bringing its total to 89,843 shares worth $10,634,000 after an additional purchase of 2,096 shares.
Another notable increase came from Creative Planning, which boosted its stake by 76.5% to own 10,338 shares valued at $1,224,000. CWM LLC also expanded its position by 160.8%, now holding 11,904 shares worth $1,409,000. Finally, the Teacher Retirement System of Texas raised its holdings by 31.5%, acquiring an additional 2,831 shares to own 11,819 shares valued at $1,399,000. Currently, institutional investors and hedge funds collectively hold 95.62% of Teleflex’s stock.
Stock Performance and Financial Metrics
On the trading front, Teleflex shares experienced a modest increase of 2.1%, opening at $105.09. Over the past year, the stock has fluctuated between a low of $100.18 and a high of $185.94. The company’s financial health is reflected in its debt-to-equity ratio of 0.67, a current ratio of 2.57, and a quick ratio of 1.53. Teleflex has a market capitalization of $4.64 billion and a price-to-earnings ratio of -14.30. Its 50-day and 200-day simple moving averages stand at $116.34 and $120.11, respectively.
Recently, Teleflex announced a quarterly dividend of $0.34 per share, which was paid on December 15, 2024. The dividend was distributed to investors on record as of November 14, 2024, with the ex-dividend date also on November 14. This quarterly payment translates to an annualized dividend of $1.36 with a yield of 1.3%. The company’s current dividend payout ratio is -18.50%.
Analyst Ratings and Market Sentiment
Recent commentary from analysts has highlighted varying perspectives on Teleflex. Weiss Ratings maintained a “sell (d)” rating on the stock, while Wells Fargo & Company adjusted its target price from $114.00 to $139.00, assigning an “equal weight” rating. Meanwhile, Needham & Company LLC reiterated a “hold” rating, and Wall Street Zen downgraded the stock from “buy” to “hold.” Zacks Research also downgraded Teleflex from a “strong-buy” to a “hold” rating.
Currently, one research analyst has rated Teleflex as a “buy,” nine analysts have issued “hold” ratings, and two have given it a “sell” rating. According to data from MarketBeat, Teleflex has a consensus rating of “reduce” and a target price of $142.43.
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is a diversified global provider of medical technologies. The company specializes in critical care and surgery, designing, manufacturing, and distributing devices used by healthcare professionals across various settings. Its product offerings encompass key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular, and Original Equipment Manufacturer (OEM) solutions.
